{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:15:32Z","timestamp":1790511332375,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["#RDAPB- 201809-2016615"],"award-info":[{"award-number":["#RDAPB- 201809-2016615"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["2017-00915"],"award-info":[{"award-number":["2017-00915"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010815","name":"Stiftelsen For Gamla Tjanarinnor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["681712"],"award-info":[{"award-number":["681712"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Familjen Erling-Perssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009673","name":"Gun och Bertil Stohnes Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021720","name":"Olav Thon Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["-21-831376-C"],"award-info":[{"award-number":["-21-831376-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["-21-831377-C"],"award-info":[{"award-number":["-21-831377-C"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["201809-2016862"],"award-info":[{"award-number":["201809-2016862"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-02532"],"award-info":[{"award-number":["2018-02532"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["-742881"],"award-info":[{"award-number":["-742881"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["2017-0243"],"award-info":[{"award-number":["2017-0243"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ebiom.2021.103793","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T12:50:25Z","timestamp":1641214225000},"page":"103793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1044-0192","authenticated-orcid":false,"given":"Elena","family":"Camporesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0761-7885","authenticated-orcid":false,"given":"Agathe","family":"Vrillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Cognat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hourregue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-4354","authenticated-orcid":false,"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Brinkmalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Paquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Brinkmalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10043","key":"10.1016\/j.ebiom.2021.103793_bib0001","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"The Lancet"},{"key":"10.1016\/j.ebiom.2021.103793_bib0002","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's Disease Is a Synaptic Failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0003","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12035-008-8018-z","article-title":"Dendritic spine loss and synaptic alterations in Alzheimer's disease","volume":"37","author":"Knobloch","year":"2008","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0004","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40478-019-0754-y","article-title":"Intersection of pathological tau and microglia at the synapse","volume":"7","author":"Vogels","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103793_bib0005","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2174\/1570159X17666190603170511","article-title":"Synaptic Elimination in Neurological Disorders","volume":"17","author":"Cardozo","year":"2019","journal-title":"Curr Neuropharmacol"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103793_bib0006","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180138","article-title":"Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models","volume":"8","author":"Taoufik","year":"2018","journal-title":"Open Biol"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103793_bib0007","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/jnc.13713","article-title":"Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students","volume":"138","author":"Lepeta","year":"2016","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103793_bib0008","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bcp.2013.12.028","article-title":"Is synaptic loss a unique hallmark of Alzheimer's disease?","volume":"88","author":"Scheff","year":"2014","journal-title":"Biochem Pharmacol"},{"issue":"13","key":"10.1016\/j.ebiom.2021.103793_bib0009","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1016\/j.celrep.2017.03.013","article-title":"Altered Synapse Stability in the Early Stages of Tauopathy","volume":"18","author":"Jackson","year":"2017","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103793_bib0010","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0011","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13195-020-00588-4","article-title":"The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease","volume":"12","author":"Colom-Cadena","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103793_bib0012","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","article-title":"Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment","volume":"27","author":"Scheff","year":"2006","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.56.1.127","article-title":"Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease","volume":"56","author":"Masliah","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103793_bib0014","doi-asserted-by":"crossref","first-page":"e68062","DOI":"10.1371\/journal.pone.0068062","article-title":"Early Hippocampal Synaptic Loss Precedes Neuronal Loss and Associates with Early Behavioural Deficits in Three Distinct Strains of Prion Disease","volume":"8","author":"Hilton","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103793_bib0015","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2021.103793_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1177271920950319","article-title":"Fluid Biomarkers for Synaptic Dysfunction and Loss","volume":"15","author":"Camporesi","year":"2020","journal-title":"Biomark Insights"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103793_bib0017","doi-asserted-by":"crossref","first-page":"e953","DOI":"10.1212\/WNL.0000000000010131","article-title":"Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer disease","volume":"95","author":"Tible","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0018","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40478-021-01119-4","article-title":"Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers","volume":"9","author":"Camporesi","year":"2021","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103793_bib0019","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nn1074","article-title":"Neurexin mediates the assembly of presynaptic terminals","volume":"6","author":"Dean","year":"2003","journal-title":"Nat Neurosci"},{"issue":"17","key":"10.1016\/j.ebiom.2021.103793_bib0020","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1073\/pnas.0502038102","article-title":"Postsynaptic assembly induced by neurexin-neuroligin interaction and neurotransmitter","volume":"102","author":"Nam","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0021","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.conb.2007.01.011","article-title":"Neurexin-neuroligin signaling in synapse development","volume":"17","author":"Craig","year":"2007","journal-title":"Curr Opin Neurobiol"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103793_bib0022","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/s11064-013-1029-9","article-title":"A matter of balance: role of neurexin and neuroligin at the synapse","volume":"38","author":"Bang","year":"2013","journal-title":"Neurochem Res"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103793_bib0023","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103208","article-title":"Neurexins cluster Ca(2+) channels within the presynaptic active zone","volume":"39","author":"Luo","year":"2020","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0024","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tins.2005.11.003","article-title":"Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function","volume":"29","author":"Dean","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.ebiom.2021.103793_bib0025","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nature07456","article-title":"Neuroligins and Neurexins Link Synaptic Function to Cognitive Disease","volume":"455","author":"S\u00fcdhof","year":"2008","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103793_bib0026","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.tins.2015.06.004","article-title":"The cellular and molecular landscape of neuroligins","volume":"38","author":"Bemben","year":"2015","journal-title":"Trends Neurosci"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103793_bib0027","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.neuron.2019.05.043","article-title":"Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons","volume":"103","author":"Marro","year":"2019","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103793_bib0028","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1523\/JNEUROSCI.0404-20.2020","article-title":"An Autism-Associated Mutation Impairs Neuroligin-4 Glycosylation and Enhances Excitatory Synaptic Transmission in Human Neurons","volume":"41","author":"Cast","year":"2021","journal-title":"J Neurosci"},{"key":"10.1016\/j.ebiom.2021.103793_bib0029","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neures.2017.10.012","article-title":"Neurexins and neuropsychiatric disorders","volume":"127","author":"Kasem","year":"2018","journal-title":"Neurosci Res"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103793_bib0030","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.neurobiolaging.2013.09.032","article-title":"Role for the neurexin-neuroligin complex in Alzheimer's disease","volume":"35","author":"Sindi","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ebiom.2021.103793_bib0031","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fphys.2012.00464","article-title":"Postsynaptic Receptors for Amyloid-beta Oligomers as Mediators of Neuronal Damage in Alzheimer's Disease","volume":"3","author":"Dinamarca","year":"2012","journal-title":"Front Physiol"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103793_bib0032","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2217\/nmt.14.54","article-title":"New insights into Alzheimer's disease pathogenesis: the involvement of neuroligins in synaptic malfunction","volume":"5","author":"Sindi","year":"2015","journal-title":"Neurodegener Dis Manag"},{"issue":"18","key":"10.1016\/j.ebiom.2021.103793_bib0033","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1074\/jbc.M116.761189","article-title":"Interaction of amyloid-beta (Abeta) oligomers with neurexin 2alpha and neuroligin 1 mediates synapse damage and memory loss in mice","volume":"292","author":"Brito-Moreira","year":"2017","journal-title":"J Biol Chem"},{"issue":"28","key":"10.1016\/j.ebiom.2021.103793_bib0034","doi-asserted-by":"crossref","first-page":"e11343","DOI":"10.1097\/MD.0000000000011343","article-title":"Low expression of aging-related NRXN3 is associated with Alzheimer disease: A systematic review and meta-analysis","volume":"97","author":"Zheng","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0035","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1038\/s41598-020-63255-6","article-title":"Neuroligin-1 is altered in the hippocampus of Alzheimer's disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers","volume":"10","author":"Dufort-Gervais","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0036","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41380-018-0242-y","article-title":"Isoform-specific cleavage of neuroligin-3 reduces synapse strength","volume":"24","author":"Bemben","year":"2019","journal-title":"Mol Psychiatry"},{"issue":"34","key":"10.1016\/j.ebiom.2021.103793_bib0037","doi-asserted-by":"crossref","first-page":"12083","DOI":"10.1523\/JNEUROSCI.2513-11.2011","article-title":"Synaptic autoregulation by metalloproteases and gamma-secretase","volume":"31","author":"Restituito","year":"2011","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103793_bib0038","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1523\/JNEUROSCI.1357-17.2017","article-title":"Proteolytic Processing of Neurexins by Presenilins Sustains Synaptic Vesicle Release","volume":"38","author":"Servi\u00e1n-Morilla","year":"2018","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103793_bib0039","doi-asserted-by":"crossref","first-page":"e19430","DOI":"10.1371\/journal.pone.0019430","article-title":"Presenilin\/\u03b3-secretase regulates neurexin processing at synapses","volume":"6","author":"Saura","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201700131","article-title":"A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease","volume":"12","author":"Brinkmalm","year":"2018","journal-title":"Proteomics Clin Appl"},{"issue":"7-8","key":"10.1016\/j.ebiom.2021.103793_bib0041","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/prca.201400178","article-title":"Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF","volume":"9","author":"Spellman","year":"2015","journal-title":"Proteomics Clin Appl"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103793_bib0042","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1021\/pr501076j","article-title":"An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease","volume":"14","author":"H\u00f6ltt\u00e4","year":"2015","journal-title":"J Proteome Res"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103793_bib0043","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-2006-9309","article-title":"Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders","volume":"9","author":"Abdi","year":"2006","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103793_bib0044","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1074\/mcp.RA118.001290","article-title":"Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid","volume":"18","author":"Lleo","year":"2019","journal-title":"Mol Cell Proteomics"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103793_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201800105","article-title":"Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease","volume":"13","author":"Sathe","year":"2019","journal-title":"Proteomics Clin Appl"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0046","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-017-0335-x","article-title":"Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease","volume":"10","author":"Duits","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.ebiom.2021.103793_bib0047","article-title":"Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70","author":"Keshavan","year":"2021","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103793_bib0048","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"The Lancet Neurology"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103793_bib0049","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103793_bib0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103793_bib0051","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/WAD.0000000000000034","article-title":"Diagnostic criteria for vascular cognitive disorders: a VASCOG statement","volume":"28","author":"Sachdev","year":"2014","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0052","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"Pt 9","key":"10.1016\/j.ebiom.2021.103793_bib0053","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2021.103793_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.annemergmed.2021.02.019","article-title":"Preventing Post-Lumbar Puncture Headache","author":"Cognat","year":"2021","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ebiom.2021.103793_bib0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.dadm.2017.04.007","article-title":"Consensus guidelines for lumbar puncture in patients with neurological diseases","volume":"8","author":"Engelborghs","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0056","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13195-019-0550-8","article-title":"Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer's disease","volume":"11","author":"Leit\u00e3o","year":"2019","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0057","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jalz.2018.08.006","article-title":"Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology","volume":"15","author":"Sandelius","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103793_bib0058","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00401-018-1851-x","article-title":"Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology","volume":"136","author":"Portelius","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103793_bib0059","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mas.21540","article-title":"The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomics","volume":"39","author":"Pino","year":"2020","journal-title":"Mass Spectrom Rev"},{"issue":"18","key":"10.1016\/j.ebiom.2021.103793_bib0060","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1021\/ac5018265","volume":"86","author":"Gu","year":"2014","journal-title":"Anal Chem"},{"key":"10.1016\/j.ebiom.2021.103793_bib0061","doi-asserted-by":"crossref","first-page":"e07794","DOI":"10.7554\/eLife.07794","article-title":"Quantitative isoform-profiling of highly diversified recognition molecules","volume":"4","author":"Schreiner","year":"2015","journal-title":"eLife"},{"issue":"7679","key":"10.1016\/j.ebiom.2021.103793_bib0062","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nature24638","article-title":"Astrocytic neuroligins control astrocyte morphogenesis and synaptogenesis","volume":"551","author":"Stogsdill","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2021.103793_bib0063","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.conb.2019.03.007","article-title":"Control of neural development and function by glial neuroligins","volume":"57","author":"Sakers","year":"2019","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.ebiom.2021.103793_bib0064","unstructured":"Trotter JH, Dargaei Z, W\u00f6hr M, Liakath-Ali K, Raju K, Essayan-Perez S, et\u00a0al. Astrocytic Neurexin-1 Orchestrates Functional Synapse Assembly. bioRxiv. 2020:2020.08.21.262097."},{"issue":"2","key":"10.1016\/j.ebiom.2021.103793_bib0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-122257","article-title":"Genetic study of neurexin and neuroligin genes in Alzheimer's disease","volume":"35","author":"Martinez-Mir","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0066","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13195-019-0475-2","article-title":"Neurexin 3 transmembrane and soluble isoform expression and splicing haplotype are associated with neuron inflammasome and Alzheimer's disease","volume":"11","author":"Hishimoto","year":"2019","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103793_bib0067","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.neurobiolaging.2015.09.004","article-title":"A truncating mutation in Alzheimer's disease inactivates neuroligin-1 synaptic function","volume":"36","author":"Tristan-Clavijo","year":"2015","journal-title":"Neurobiol Aging"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103793_bib0068","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2174\/1567205013666160314150501","article-title":"Molecular Basis of Familial and Sporadic Alzheimer's Disease","volume":"13","author":"Dorszewska","year":"2016","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103793_bib0069","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1074\/jbc.M110.142521","article-title":"Processing of the synaptic cell adhesion molecule neurexin-3beta by Alzheimer disease alpha- and gamma-secretases","volume":"286","author":"Bot","year":"2011","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103793_bib0070","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ebiom.2021.103793_bib0071","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3389\/fneur.2019.01140","article-title":"Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease","volume":"10","author":"Ding","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.ebiom.2021.103793_bib0072","doi-asserted-by":"crossref","first-page":"42548","DOI":"10.1038\/srep42548","article-title":"Amyloid-\u03b2 Oligomers Interact with Neurexin and Diminish Neurexin-mediated Excitatory Presynaptic Organization","volume":"7","author":"Naito","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0073","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbrc.2015.08.107","article-title":"The soluble extracellular fragment of neuroligin-1 targets Abeta oligomers to the postsynaptic region of excitatory synapses","volume":"466","author":"Dinamarca","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"5713","key":"10.1016\/j.ebiom.2021.103793_bib0074","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.1107470","article-title":"Control of excitatory and inhibitory synapse formation by neuroligins","volume":"307","author":"Chih","year":"2005","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103793_bib0075","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neuron.2009.08.023","article-title":"Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin","volume":"63","author":"Poulopoulos","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.ebiom.2021.103793_bib0076","article-title":"Neurexins in autism and schizophrenia-a review of patient mutations, mouse models and potential future directions","author":"Tromp","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0077","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13041-018-0375-6","article-title":"GABAergic deficits and schizophrenia-like behaviors in a mouse model carrying patient-derived neuroligin-2 R215H mutation","volume":"11","author":"Jiang","year":"2018","journal-title":"Mol Brain"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103793_bib0078","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41398-019-0660-x","article-title":"Synaptic deficits in iPSC-derived cortical interneurons in schizophrenia are mediated by NLGN2 and rescued by N-acetylcysteine","volume":"9","author":"Kathuria","year":"2019","journal-title":"Transl Psychiatry"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103793_bib0079","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.pharep.2014.04.011","article-title":"Neuroligins, synapse balance and neuropsychiatric disorders","volume":"66","author":"Ma\u0107kowiak","year":"2014","journal-title":"Pharmacol Rep"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103793_bib0080","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1080\/14728222.2016.1188080","article-title":"Synaptic alterations associated with depression and schizophrenia: potential as a therapeutic target","volume":"20","author":"Calabrese","year":"2016","journal-title":"Expert Opin Ther Targets"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103793_bib0081","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/gm102","article-title":"Genetic overlap between autism, schizophrenia and bipolar disorder","volume":"1","author":"Carroll","year":"2009","journal-title":"Genome Med"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421005879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421005879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:12:02Z","timestamp":1762456322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421005879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":81,"alternative-id":["S2352396421005879"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103793","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103793"}}